NCT07760051

Brief Summary

The goal of this clinical trial is to evaluate whether AI-assisted workflows improve physicians' admission diagnosis performance on standardized simulated inpatient cases, among practicing internal medicine and surgery physicians across all seniority levels and across three tiers of the Chinese healthcare system. The main questions it aims to answer are:

  • Does the Agent-assisted workflow yield better structured admission diagnosis scores than standalone LLM assistance?
  • Does the Agent-assisted workflow outperform the traditional workflow without AI tools? Researchers will compare three parallel groups (traditional workflow group, LLM-only group, Agent group) to determine whether the Agent tool can improve diagnostic accuracy and efficiency. Participants will:
  • Be recruited from 15 hospitals in China and participate remotely under video proctoring
  • Be randomly assigned to one of the three fixed workflows, with randomization stratified by hospital tier, specialty and seniority
  • Complete 6 anonymized simulated HIS admission cases within one hour
  • Submit structured answers for each case covering principal diagnosis, secondary diagnoses, differential diagnoses, diagnostic justification, next diagnostic or therapeutic steps, consultation and referral decisions, and diagnostic confidence
  • Have their operation logs and time consumption recorded automatically by the study platform

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
3mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
20 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 12, 2026

Status Verified

August 1, 2026

Enrollment Period

3 months

First QC Date

July 29, 2026

Last Update Submit

August 9, 2026

Conditions

Keywords

large language modelAI agentclinical decision supportadmission diagnosisdiagnostic accuracydiagnostic reasoningrandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Mean Normalized Structured Diagnostic Reasoning Score

    Mean of the rescaled case scores (each case rescaled to 100), divided by the number of cases completed; range 0 to 100.

    Within one-hour study

Secondary Outcomes (3)

  • Degree of Adherence to AI-Generated Recommendations

    Within one-hour study

  • Active Response Time per Case

    Within one-hour study

  • Normalized Score for Next Diagnostic or Therapeutic Steps

    Within one-hour study

Study Arms (3)

Agent group

EXPERIMENTAL
Other: Agent Workflow

LLM group

EXPERIMENTAL
Other: LLM Workflow

traditional group

ACTIVE COMPARATOR
Other: traditional workflow

Interventions

Conventional resources (pre-admission clinical record, search engines) plus an in-system Agent entry that automatically reads the full record and report images, produces a structured summary with source-text tracing, and supports multi-turn Q\&A and one-click editable drafts.

Agent group

Conventional resources plus an in-system multi-turn AI dialogue entry. The AI does not automatically read the record; participants paste text or send partial screenshots.

LLM group

Conventional resources only: the pre-admission clinical record, standard search engines. No AI assistance.

traditional group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hold a Medical Practitioner Qualification Certificate and/or Medical License, or be a recognized standardized resident physician; able to independently read electronic medical records, laboratory and imaging reports on an HIS.
  • Currently engaged in clinical work in internal medicine or surgery at one of the 15 participating hospitals.
  • Able to complete the 1-hour case assessment and the preceding training module and qualification test.
  • Able to participate remotely under video proctoring, with a stable internet connection and a working camera.
  • Voluntarily agree to participate and sign the informed consent form, including the declaration not to use unauthorized AI tools during the assessment.
  • Have not participated in case drafting, review, rubric development, or any activity that may leak the reference standard.
  • Stratified enrollment by hospital tier (provincial tertiary, municipal, primary care), specialty (internal medicine, surgery) and seniority (senior = Associate Chief Physician or above; junior-to-mid-level = below Associate Chief Physician, prioritizing residents, attending physicians and those with ≤ 8 years of practice).

You may not qualify if:

  • Have previously accessed the official test cases or reference standard of this study.
  • Unable to complete the training module, qualification test, or all experimental tasks.
  • Have conflicts of interest, e.g. participation in developing core algorithms of the tested system.
  • Unwilling to comply with remote proctoring, including keeping the camera on throughout.
  • Violate study rules during the assessment (unauthorized AI tools, discussing cases, copying answers).
  • Judged unsuitable by the investigators.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310009, China

Location

Study Officials

  • Yuan Ding

    Second Affiliated Hospital, Zhejiang University, School of Medicine

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Participants and investigators cannot be masked, as the intervention is the workflow itself. Outcome assessors scoring the structured answers are blinded to group allocation; submitted answers are anonymized and stripped of workflow-identifying information before scoring.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Three-arm parallel-group design with 1:1:1 allocation. All arms share the same conventional resources (pre-admission clinical record, search engines); the arms differ only in the AI entry added on top (none / LLM / Agent). Randomization is stratified by hospital tier, specialty and seniority.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2026

First Posted

August 12, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 12, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations